Literature DB >> 31857377

Current opinion, status and future development of digital pathology in Switzerland.

Julia Unternaehrer1, Rainer Grobholz2, Andrew Janowczyk3, Inti Zlobec4.   

Abstract

AIMS: The transition from analogue to digital pathology (DP) is underway in Switzerland. To assess relevant experiences of pathologists with DP and gauge their outlook towards a digital future, a national survey was conducted by the Swiss Digital Pathology Consortium. Similar surveys were conducted in other countries, enabling a meta-analysis of DP experiences.
METHODS: Pathologists and residents were asked to complete a survey containing 12 questions. Results were compared with similar studies conducted in the United Kingdom, Sweden, Canada, and India.
RESULTS: The estimated response rate among practicing pathologists and trainees nationwide was 39.5%. Of these, 89% have experience with digital slides, mainly for education (61%) and primary diagnostics (20%). Further, 32% have worked with an image analysis programme and 26% use computer-based algorithms weekly. Interestingly, 66% would feel comfortable making a primary diagnosis digitally, while 10% would not. Most respondents believe more standards and regulations are necessary for the clinical employment of DP. Noted advantages include ease of access to slides and the resulting connectivity benefits, namely collaboration with experts across disciplines, off-site work, training purposes, and computational image analysis. Perceived disadvantages include implementation costs and issues associated with IT infrastructure and file formats.
CONCLUSION: The survey results suggest that experiences and perspectives of Swiss pathologists concerning DP is comparable to that of the other reporting countries undergoing transitions to digital workflows. Although more standards and regulations are needed to ensure the safe usage of these technologies, pathologists in Switzerland appear welcoming of this new digital era. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  diagnostics; digital pathology; image analysis

Mesh:

Year:  2019        PMID: 31857377     DOI: 10.1136/jclinpath-2019-206155

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

Review 1.  The Lancet Commission on diagnostics: transforming access to diagnostics.

Authors:  Kenneth A Fleming; Susan Horton; Michael L Wilson; Rifat Atun; Kristen DeStigter; John Flanigan; Shahin Sayed; Pierrick Adam; Bertha Aguilar; Savvas Andronikou; Catharina Boehme; William Cherniak; Annie Ny Cheung; Bernice Dahn; Lluis Donoso-Bach; Tania Douglas; Patricia Garcia; Sarwat Hussain; Hari S Iyer; Mikashmi Kohli; Alain B Labrique; Lai-Meng Looi; John G Meara; John Nkengasong; Madhukar Pai; Kara-Lee Pool; Kaushik Ramaiya; Lee Schroeder; Devanshi Shah; Richard Sullivan; Bien-Soo Tan; Kamini Walia
Journal:  Lancet       Date:  2021-10-06       Impact factor: 79.321

2.  On the Road to Digital Pathology in Denmark-National Survey and Interviews.

Authors:  Julie Smith; Sys Johnsen; Mette Christa Zeuthen; Lisbeth Koch Thomsen; Niels Marcussen; Stig Hansen; Charlotte Lerbech Jensen
Journal:  J Digit Imaging       Date:  2022-05-24       Impact factor: 4.903

3.  Global research trends and foci of artificial intelligence-based tumor pathology: a scientometric study.

Authors:  Zefeng Shen; Jintao Hu; Haiyang Wu; Zeshi Chen; Weixia Wu; Junyi Lin; Zixin Xu; Jianqiu Kong; Tianxin Lin
Journal:  J Transl Med       Date:  2022-09-06       Impact factor: 8.440

Review 4.  Digital pathology - Rising to the challenge.

Authors:  Heather Dawson
Journal:  Front Med (Lausanne)       Date:  2022-07-22

5.  Towards a national strategy for digital pathology in Switzerland.

Authors:  Andrew Janowczyk; Daniel Baumhoer; Stefan Dirnhofer; Rainer Grobholz; Anja Kipar; Laurence de Leval; Doron Merkler; Olivier Michielin; Holger Moch; Aurel Perren; Sven Rottenberg; Laura Rubbia-Brandt; Mark A Rubin; Christine Sempoux; Markus Tolnay; Inti Zlobec; Viktor Hendrik Koelzer
Journal:  Virchows Arch       Date:  2022-05-27       Impact factor: 4.535

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.